AIIMS Delhi has begun the trial of Bharat Biotech’s Covaxin on children from Monday. The Drug Controller General of India (DCGI) had given its approval on May 13 for the clinical trial of Covaxin on children. 18 children will be included in the first phase of the trial. In this 8-week trial, the effect of the vaccine on children and the body’s immunity will be studied. In AIIMS Patna, clinical trial of this vaccine has already started from June 3 on children aged 2 to 18 years. According to pandemic experts, children can be more susceptible to the infection during the second wave of COVID-19. Nagpur-based Meditrina Institute of Medical Science has also been selected for clinical trial of this vaccine on children.
*Please create a profile first to EARN & REDEEM points
AIIMS Delhi starts screening children for Covaxin trials from today
We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.